TickerFactsScreenerDevelopers

TuHURA Biosciences, Inc./NV (HURA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$38.8K2014: -$4.00M2015: -$3.85M2016: -$5.15M2017: -$8.02M2018: -$9.85M2019: -$6.33M2020: -$7.93M2021: -$18.86M2022: -$20.39M2023: -$11.95M2024: -$14.73M2025: -$27.63M-$27.63M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$27.63M-87.6%
2024-$14.73M-23.2%
2023-$11.95M+41.4%
2022-$20.39M-8.1%
2021-$18.86M-137.9%
2020-$7.93M-25.3%
2019-$6.33M+35.8%
2018-$9.85M-22.8%
2017-$8.02M-55.8%
2016-$5.15M-33.6%
2015-$3.85M+3.8%
2014-$4.00M—
2011-$38.8K—